Chunghwa Chemical Synthesis & Biotech : Approved to release non-compete restrictions on newly elected directors and authorized representatives.

Close

Today's Information

Provided by: Chunghwa Chemical Synthesis & Biotech Co.,Ltd
SEQ_NO	3	Date of announcement	2022/05/25	Time of announcement	17:35:29
Subject	Approved to release non-compete restrictions on newly elected directors and authorized representatives.
Date of events	2022/05/25	To which item it meets	paragraph 21
Statement	1.Date of the shareholders meeting resolution:2022/05/25 2.Name and title of the director with permission to engage in competitive conduct: Directors:Representative of CHINA CHEMICAL & PHARMACEUTICAL CO., LTD./ WANG HSIEH YI-CHEN Directors:Representative of CHINA CHEMICAL & PHARMACEUTICAL CO., LTD./ WANG, HOU-KAI Directors:Representative of WANG MING-NING MEMORIAL FOUNDATION./ HUANG ,JONG-SHINN Directors:Representative of WANG MING-NING MEMORIAL FOUNDATION./ WANG, HOU -JIE Independent Directors：WANG ,KUO-CHIANG Independent Directors：CHANG ,CHIH-HSIEN Independent Directors：KUAN ARTHUR 3.Items of competitive conduct in which the director is permitted to engage: (1)Directors:Representative of CHINA CHEMICAL & PHARMACEUTICAL CO., LTD. /WANG HSIEH YI-CHEN A.Chairman of China Chemical & Pharmaceutical Co., Ltd. (Chunghwa Chemical Synthesis & Biotech Co. Ltd. legal representative) B.Chairman of Chunghwa Yuming Healthcare Co., Ltd. (China Chemical & Pharmaceutical Co., Ltd. legal representative) C.Chairman of Chunghwa Senior Care Co., Ltd. (China Chemical & Pharmaceutical Co., Ltd. legal representative) D.Chairman of Tairung Development Co., Ltd. E.Chairman of HU-YU Co., Ltd. F.Chairman of Majiade Enterprises Co., Ltd. (2)Directors:Representative of CHINA CHEMICAL & PHARMACEUTICAL CO., LTD./ WANG, HOU-KAI Strategic Business Development Vice President, Chunghwa Yuming Healthcare Co., Ltd. (3)Directors:Representative of WANG MING-NING MEMORIAL FOUNDATION./ HUANG ,JONG-SHINN A.President of Chunghwa Chemical Synthesis & Biotech Co., Ltd. B.Chairman of PHARMAPORTS,LLC (Chunghwa Chemical Synthesis & Biotech Co. Ltd. legal representative) C.General director of Sino-Japan Chemical Co., Ltd. (China Chemical & Pharmaceutical Co., Ltd. legal representative) (4)Directors:Representative of WANG MING-NING MEMORIAL FOUNDATION./ WANG, HOU -JIE A.Director and Vice President of Suzhou Chung-Hwa Chemical Pharmaceutical Industrial Co., Ltd. B.Director of China Chemical & Pharmaceutical Co., Ltd. (Wang Ming-Ning Memorial Foundation legal representative) C.Director of Tairung Development Co., Ltd. (5)Independent Directors：WANG ,KUO-CHIANG A.Davicom Semiconductor, Inc. managing director B.Partner Tech Corp. independent director, remunerations committee commissioner, audit committee commissioner. C.Feedback Tech. Corp. independent director, remunerations committees commissioner, audit committee commissioner, merger special committee commissioner. D.Independent Director, Convener of Compensation and Remuneration Committee, and Convener of Audit Committee, Hill Source Holdings Limited (KY Company) E.Assistant Professor of National Yang Ming Chiao Tung University (6)Independent Directors：CHANG ,CHIH-HSIEN A.Vision Thinktank Co., Ltd. CEO B.Special assistant to the hosting architect of Partners Architects Planners C.Head of Finance, JIA-TENG Construction Group (7)Independent Directors：KUAN ARTHUR A.Chairman and President (Acting), Allied Industrial Corp., Ltd. B.Chief Executive Officer and Board Director, CG Oncology (Eternal Facial Biotechnology Co., Ltd.) C.Partner, Perseverance Capital Management 4.Period of permission to engage in the competitive conduct: During the tenure of director post. 5.Circumstances of the resolution (please describe the results of voting in accordance with Article 209 of the Company Act): Approved by more than two-thirds of voting rights of attending shareholders, who hold more than half of the total number of shares issued. 6.If the permitted competitive conduct belongs to the operator of a mainland China area enterprise, the name and title of the directors (if it is not the operator of a Mainland-area enterprise, please enter "N/A" below): Directors:Representative of WANG MING-NING MEMORIAL FOUNDATION./ WANG, HOU -JIE 7.Company name of the mainland China area enterprise and the director's position in the enterprise: Director and Vice President of Suzhou Chung-Hwa Chemical Pharmaceutical Industrial Co., Ltd. 8.Address of the mainland China area enterprise: No. 66, Yongan Road, New District, Suzhou, Jiangsu 9.Operations of the mainland China area enterprise: pharmaceutical products/ Production and sale of health care products 10.Impact on the company's finance and business:None 11.If the directors have invested in the mainland China area enterprise, the monetary amount of the investment and their shareholding ratio:N/A 12.Any other matters that need to be specified:None